News News
Your current location:
Homepage
>
>
>
Zhejiang Lepu Pharmaceutical Co., Ltd. signed an agreement with the Taizhou Research Institute of SUSTech to build a joint R&D center

Zhejiang Lepu Pharmaceutical Co., Ltd. signed an agreement with the Taizhou Research Institute of SUSTech to build a joint R&D center

  • Categories:Company News
  • Time of issue:2020-11-17 14:40
  • Views:

(Summary description)On October 12, 2020, Zhejiang Lepu Pharmaceutical, Southern University of Science and Technology Taizhou Research Institute and Taizhou Aisente Technology Co., Ltd. held a joint R&D center signing ceremony in Zhejiang Lepu Pharmaceutical Co., Ltd. Ai Jianqi, Dean of Taizhou Research Institute of Southern University of Science and Technology, General Manager of Taizhou Ascent Technology Co., Ltd., Doctoral Supervisor Professor Zhang Xumu, and General Manager Hong Huabin of Zhejiang Lepu Pharmaceutical Co., Ltd. attended the signing ceremony.

Zhejiang Lepu Pharmaceutical Co., Ltd. signed an agreement with the Taizhou Research Institute of SUSTech to build a joint R&D center

(Summary description)On October 12, 2020, Zhejiang Lepu Pharmaceutical, Southern University of Science and Technology Taizhou Research Institute and Taizhou Aisente Technology Co., Ltd. held a joint R&D center signing ceremony in Zhejiang Lepu Pharmaceutical Co., Ltd. Ai Jianqi, Dean of Taizhou Research Institute of Southern University of Science and Technology, General Manager of Taizhou Ascent Technology Co., Ltd., Doctoral Supervisor Professor Zhang Xumu, and General Manager Hong Huabin of Zhejiang Lepu Pharmaceutical Co., Ltd. attended the signing ceremony.

  • Categories:Company News
  • Time of issue:2020-11-17 14:40
  • Views:
Information

On October 12, 2020, Zhejiang Lepu Pharmaceutical, Southern University of Science and Technology Taizhou Research Institute and Taizhou Aisente Technology Co., Ltd. held a joint R&D center signing ceremony in Zhejiang Lepu Pharmaceutical Co., Ltd. Ai Jianqi, Dean of Taizhou Research Institute of Southern University of Science and Technology, General Manager of Taizhou Ascent Technology Co., Ltd., Doctoral Supervisor Professor Zhang Xumu, and General Manager Hong Huabin of Zhejiang Lepu Pharmaceutical Co., Ltd. attended the signing ceremony.

The main function of the R&D center is to use the unique asymmetric catalysis technology of Professor Zhang Xumu (an internationally renowned coordination chemist and metal organic chemist) to jointly develop innovative biomedical projects and jointly cultivate biomedical talents.

The joint signing of the three parties this time marks an important step taken by the hospital and enterprises in opening up substantive partners. The establishment of the joint R&D center will enable the two parties to deeply integrate in the fields of personnel training, new drug research and development, and to obtain effective complementarity in technological innovation and process improvement, and realize multi-party resource sharing.

Keyword:

Scan the QR code to read on your phone

11-17

Zhejiang Lepu Pharmaceutical Co., Ltd. signed an agreement with the Taizhou Research Institute of SUSTech to build a joint R&D center

On October 12, 2020, Zhejiang Lepu Pharmaceutical, Southern University of Science and Technology Taizhou Research Institute and Taizhou Aisente Technology Co., Ltd. held a joint R&D center signing ceremony in Zhejiang Lepu Pharmaceutical Co., Ltd. Ai Jianqi, Dean of Taizhou Research Institute of Southern University of Science and Technology, General Manager of Taizhou Ascent Technology Co., Ltd., Doctoral Supervisor Professor Zhang Xumu, and General Manager Hong Huabin of Zhejiang Lepu Pharmaceutical Co., Ltd. attended the signing ceremony.
11-17

Zhejiang Lepu Pharmaceutical starts weekly learning meetings

In order to accelerate the legalization and normalization of the second phase of the technical transformation project for solid preparations with an annual output of 1.5 billion (tablets, granules), according to relevant regulations, on October 13, 2020
11-17

The second phase of Lepu Pharmaceutical Technology's annual output of 1.5 billion (tablets, granules) solid preparation technological transformation project passed the safety completion acceptance

In order to accelerate the legalization and normalization of the second phase of the technical transformation project for solid preparations with an annual output of 1.5 billion (tablets, granules), according to relevant regulations
11-17

Shen Yinchu, academician of the Chinese Academy of Engineering, came to Zhejiang Lepu to guide scientific research

On September 30th, Shen Yinchu, academician of the Chinese Academy of Engineering, and his entourage came to our company to guide scientific research work. After visiting the company's exhibition hall and preparation production workshop
11-17

Zhejiang Lepu Pharmaceutical organizes party members to attend party classes

On August 21, Zhejiang Lepu Pharmaceutical organized more than 50 middle and high-level party members of the company to attend party classes. General Manager Hong Huabin gave a profound party lesson to party members and cadres at the meeting.
11-17

Leaders of Zhejiang Food and Drug Administration investigate Zhejiang Lepu Pharmaceutical

On September 17, Shao Yuanchang, deputy director of Zhejiang Provincial Drug Administration, accompanied by leaders of the two-level market supervision administration of Taizhou City, went to Zhejiang Lepu Pharmaceutical to conduct the "three services" of serving enterprises, serving the masses, and serving the grassroots. Research work.
Previous page
1
2
这是描述信息

Support Hotline

QR code

Scan to enter

Copyright © 2021 Zhejiang LePu Pharmaceutical Co., Ltd. All rights reserved 浙ICP备17026965号 Powered by www.300.cn